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ABSTRACT 
 
 
 
 Generating a Consistent Framework for Evaluating Cell Response to External Stimuli 
through Epigenetic Assessors. (May 2011) 
Bo Wang, B.S., Tianjin University 
Chair of Advisory Committee: Dr. Mariah Hahn 
 
 
 
 
  Mesenchymal stem cells are more and more widely used in tissue engineering due to 
their pluripotency and no relative ethical problems. Traditional characterization 
techniques to detect mesenchymal stem cell states include flow cytometry, gene 
expressing profiling and immunohistochemistry. However, these methods can only 
provide transient and low level information from current RNA or protein levels about 
mesenchymal stem cells, which may cause problems when predicting the possible 
downstream lineages they will commit into. 
  We have developed chromatin immunoprecipitation (ChIP)-based epigenetic 
technique to detect mesenchymal stem cell states. For the systems we tested, this 
epigenetic assessor successfully characterized cell state changes and gave similar results 
obtained from gene expression profiling or protein expression assay. This epigenetic 
technique can provide information about mesenchymal stem cells states from a more 
fundamental chromatin level, which is promising for predicting future lineages from 
current states.  
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1. INTRODUCTION 
 1.1 Mesenchymal stem cells (MSC) in tissue engineering 
  Tissue loss or end-stage organ failure causes more and more severe problems all over 
the world. Every year, the total national health care cost for patients suffering these 
problems exceeds $400 billion in US alone (1). As a traditional treatment, tissue 
transplantation saves a large number of patients (1). However, due to the donor shortage 
and increasing number of patients, people are looking for new curing methods. Since its 
foundation, tissue engineering (1, 2) has been used more and more. During the decade, 
FDA has approved the application of a larger number of artificial tissues in vivo (3). 
Stem cells expose their great potential for application in tissue engineering (4) since 
they were discovered. Various kinds of stem cells have been investigated clinically (5, 6). 
Among these, mesenchymal stem cells (MSC) are most widely used as a result of their 
pluripotency and none ethical problems associated. They are able to differentiate into 
osteoblasts, chondrocytes, adipocytes and myocytes under corresponding stimuli. Our 
lab has a long history of studying mouse mesenchymal stem cells. We have successfully 
investigated the effects of pore size and modulus of matrices on their differentiation in 
3D cultures (7, 8). 
MSC behavior at a given time point is the output result of a multitude of input stimuli 
(Figure 1), each of which influences cell gene expression through modulation of internal 
signaling pathways. These stimuli act individually and in concert to direct MSC lineage 
progression. Soluble factors, such as TGF-β and dexamethasone, are currently the most 
widely used means of directing MSC differentiation. However, MSC responses to 
soluble signals can be profoundly influenced by the concomitant, matrix-mediated 
signals the cells receive. For instance, the osteogenic tendency of MSCs cultured in the 
 This thesis follows the style of Proceedings of the National Academy of Science of the 
United States of America. 
2 
 
 
 
 
Figure 1 Cell response is affected by a variety of input stimuli including: (1) soluble 
regulators; (2) external strain; (3) cell-cell interactions; (4) matrix properties (matrix- 
mediated stimuli); and (5) initial cell state 
 
 
 
presence of dexamethasone and ascorbic acid on collagen type I-coated tissue culture 
polystyrene (TCPS) is effectively negated on fibronectin-coated TCPS (9). 
  Over the past two decades, the multiple facets of matrix-mediated signaling, beyond 
the identity and concentration of biochemical cues, have become increasingly 
appreciated (10, 11). For example, integrins, cell surface receptors which interact with a 
range of ECM proteins, were first recognized for their function in translating biopolymer 
identity into a cell response (11). However, they also act as mechanical transducers by 
serving as organizing centers for focal adhesion complexes and associated cytoskeletal 
networks. The profound effects of integrin-mediated translation of matrix elastic 
modulus on MSC lineage commitment has been elegantly demonstrated in 2D using 
collagen I-coated polyacrylamide gels.    
  Despite these advances, our understanding of cell behavior is not yet sufficient to 
enable the rational selection of stimuli to elicit desired cell responses. Indeed, the 
literature contains a number of recent examples of the same apparent stimuli being 
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applied to MSCs with markedly different outcomes. For instance, a recent study found 
that MSCs cultured in alginate gels in the presence of TGF-β and dexamethasone 
displayed decreased chondrogenic potential with increasing levels of integrin-adhesion 
peptide RGD (12). In contrast, a separate study reported that MSCs cultured in 
PEG-based hydrogels, also in the presence of TGF-β and dexamethasone, showed 
increased chondrogenic potential with increasing RGD concentration (13). Since neither 
PEG nor alginate interacts significantly with cells and since neither study characterized 
gel modulus, the source of the discrepancy between the two studies is, as is often the 
case, unclear. Such inconsistencies limit our ability to rationally guide MSC lineage 
progression. 
  A fundamental premise is that many of these apparently conflicting results are actually 
consistent, but appear to be in disagreement due to the need for further specification 
and/or control of the context in which cell stimulation is occurring. Three primary 
contextual factors include: 1. the complexity of microenvironments normally used to 
study matrix-mediated signaling (this complexity frequently confounds questions of 
relative stimuli impact); 2. differences in the initial cell population “state” not accounted 
for by conventional cell marker assessments; 3.differences in the stage of temporal 
evolution at which the system is examined.  
  Moreover, as the most widely used technique to characterize cells states in artificial 
tissues, immunohistochemistry can not give the quantitative state of cells due to its 
qualitative property. Unspecific background binding of antibodies can also happen all 
the time, which will result in inexact conclusions. In this case, a new detection 
technology is needed to characterize cell states in artificial tissues to help identifying the 
function of them more exactly. 
  The overall goal of this work is to develop a ChIP (chromatin 
immunoprecipitation)-based epigenetic method to characterize differential states of stem 
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cells in artificial tissues.  
  An additional key challenge to the development of cause-effect relationships arises from 
the limited characterization of initial “cell state” incorporated in most tissue engineering 
studies. Current MSC characterization methods serve as an excellent example of this. The 
pluripotent character of MSCs is, at present, generally assessed by flow cytometry 
analyses of a set of cell markers (CD105+, CD44+, CD166+, CD29+, CD14-, CD34-, 
CD45-). Despite the continued expansion of this cell marker set, dramatic variations in the 
differentiation potential of “confirmed” MSCs (i.e. MSCs with quantitatively similar cell 
marker profiles) are documented (14). Importantly, not all of these behavioral differences 
can be attributed to genetics. Thus, there are critical aspects of MSC pluripotency which 
are not being captured by these conventional cell marker analyses. Similar comments 
apply to primary differentiated cells. Thus, improved methods for characterizing “cell 
state” are needed to enable discovery of causative relationships between applied input 
stimuli and observed cell responses.   
  But what are these “improved”/”adequate” assessors? Gene expression data alone are 
insufficient, because the gene expression analyses provide only a momentary snapshot of 
the cell while giving limited insight into the direction in which the cell is headed. 
Transcription factor profiles can give deeper insight into future paths of cell response, 
but are also not adequate. This is because transcription takes place on promoter DNA 
within the context of chromatin and that the structure of this chromatin plays an active 
and fundamental role in transcriptional control. To see this, we can examine the two 
distinct histone landscapes, shown schematically in Figure 2 for a gene expressed in 
response to binding of transcription factor SRF. Even if the cell is expressing abundant 
SRF, the expression of SRF-induced genes will be low if the gene histone-coding pattern 
is of a heterochromatic format. Thus, our hypothesis is that some level of the cell 
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population-average, epigenetic landscape must be characterized, in conjunction with 
transcription factors profiles, to adequately specify “cell state”. To test this hypothesis, 
we will exploit differences in the differentiation potentials of three mouse embyronic 
mesodermal-derived cell lines: C3H/10T1/2, NIH/3T3and 3T3-L1. We have chosen to 
use these pluripotent cell lines instead of human MSCs, since these mouse cell lines 
retain the pluripotency characteristic of human MSCs while giving more highly 
reproducible responses with population doubling. This consistency in initial “cell state” 
with general cell expansion is required for the rapid screening of chromatin-based 
assessors indicative of alterations in cell responses induced by an applied stimulus. 
Although the use of mouse cells does mean that our work will be less immediately 
applicable to the human system, the results will establish a framework which can one 
day be expanding to understanding human MSCs. 
 
 
 
 
Figure 2 Chromatin landscape of a cellular gene whose expression is regulated by 
transcription factor SRF 
 
 
 
  The distinctions in the differentiation tendencies among the three selected model cell 
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lines are broadly depicted in Figure 3. Specifically, 10T1/2 cells have a tendency to 
progress toward muscle-like fates, while the random fate decisions of NIH/3T3cells 
appear to be more evenly distributed among potential lineages. It is our premise that 
these consistent differences in tendency reflect differences in initial “cell state” 
(epigenetic landscape) among the cell lines. However, restricting our observations to 
10T1/2 and NIH/3T3cells would not allow us to rule out genetic effects as a primary 
source of observed differences. Therefore, we will also examine the stimuli responses of 
3T3-L1 cells, a line directly derived from and genetically identical to NIH/3T3cells but 
with significantly altered differentiation tendencies. 
 
 
 
 
Figure 3 3T3-L1, NIH/3T3 and C3H/10T1/2 cells are mouse mesodermal or mouse 
mesodermal-derived cells 
 
 
 
  In executing the proposed studies, we will expose each of the three cell lines to the 
same stimulus combinations and screen for alterations associated with the induced 
population fate decisions via two methods: 1. comparison of alterations in the 
protein-level profiles of standard cell markers associated with retention of pluripotency 
as well as a subset of transcription factors associated with lineage specific differentiation 
(Table 1); 2.comparison of alterations in the histone profiles of genes associated with 
pluripotency and genes encoding for transcription factors associated with lineage 
specific differentiation. For approach 2, a limited subset of histone modifications (3-4 
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different modifications) will be examined per screening cycle, with 2 examples of 
common histone modifications given in Table 1. By combining these various assessors 
of alterations in population average “cell state” induced by the application of a specific 
stimulus with systems biology approaches, we will identify histone-code “signatures” 
which are highly correlated with observed population average, cell-fate trajectories. 
While these initial associations will be inherently correlative, the establishment of these 
initial correlative links will enable later assessment of causative links. 
  Futhermore, the model systems we choose are all valid model systems as all of the 
three kinds of cells are used a lot in tissue engineering (15, 16, 17). Combining the 
changes in all three stages of DNA (histone modifications), RNA and protein can give us 
an integrative overview of cell states, which is more complete than the information that 
can be obtained through immunohistochemistry. Moreover, the study of these model 
systems can provide more promise for application of this method in other cell systems, 
or even in the whole tissue engineering. 
 
 
 
Table 1 Example of genes and histones to be examined 
Standard Genes associated with 
Specific Cell Population Lineage 
Progression 
Two Examples of Common Histone 
Modifications 
Multipotent: CD105 
Osteogenic: Runx2 
Chondrogenic: Sox9 
Smooth Muscle: Myocardin 
Myogenic: MyoD  
Adipogenic: PPARγ 
H4Ac: generally associated with euchromatin 
H3K27Me3: generally associated with 
heterochomatin 
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 1.2 Epigenetic assessors for detection of stem cell states 
  To our knowledge, this is the first time that epigenetic study has undergone in tissue 
engineering. Epigenetics has been studied for a long time (18), and recently, more and 
more physiological phenomena have been related with epigenetic reprogramming in 
vivo (19). Moreover, a lot of work has been done on the characterization of the 
epigenetic states of stem cells (20). However, little work has been done on the 
identification of epigenetic states during differentiation process of stem cells, especially 
for those encapsulated in artificial tissues. Our work provides ways to investigate these 
basic chromatin dynamics to better understand the mechanisms of stem cells 
differentiation, to direct their differentiation more effectively and to predict their 
differentiation from DNA stage, a much deeper perspective than from protein stage, 
which is normally revealed by immunohistochemistry. 
  Stem cells play a very important role in tissue engineering (4). Once they are 
encapsulated in artificial matrices, they can be directed to differentiate into various kinds 
of cells depending on the small moieties in the matrices (21), or the elasticity of matrices 
(10, 22). On the other hand, different growth factors or motifs can be cross-linked in the 
matrices either physically or chemically to guide differentiation more specifically and 
efficiently (23, 24).  
  Stem cells are also well characterized in their epigenetic states (20), expression 
profiles (25) and pluripotency (26). Epigenetic studyusually consists of two different 
aspects: methylation in DNA CpG islands (27) and histone modifications in chromatins 
(28). 
  DNA methylation involves the addition of a methyl group to the 5 position of the 
cytosine pyrimidine ring, which may be essential for normal development and is 
associated with a number of key processes including genomic imprinting, 
X-chromosome inactivation, suppression of repetitive elements and carcinogenesis. 
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There are large numbers of repeating sequences in mammalian cells, which are full of 
CpG dinucleotides. Once methylated, transcription factors may not be able to bind to the 
gene, which will lead transcriptional silencing. The most common technique used to 
characterize DNA methylation is bisulfite sequencing. Treatment of DNA 
with bisulfite converts cytosine residues to uracil, but leaves 5-methylcytosine resi- dues 
unaffected. Then specific primers are used to sequence the fragment, providing single 
nucleotide resolution information about the methylated sites. So a sequencer is needed to 
detect methylation in DNA. Due to the limit of instruments, at this stage, our work will 
focus on histone modifications in chromatin, which is characterized very well in stem 
cells (20).  
  Chromatins are composed of DNA and histones, both of which are dynamic in vivo. 
Histones are composed of four core subunits H2A, H2B, H3 and H4 and two linker units 
H1 and H5. Two of each of the four core histones form an octameric assembly and 147 
bp of DNA winds the assembly to form a nucleosome. Histone modifications include 
methylation, acetylation and phosphorylation of specific amino acid residues. Figure 4 
shows the scheme of histone modification pathways (29). Among these four core 
histones, modifications usually occur on lysine, serine and arginine residues in H3 and 
H4 (29, 30, 31, 32, 33) (Figure 4). Different histone modifications will cause chromatin 
to alter between euchromatin, which is a lightly packed form of chromatin and under 
active transcription, and heterochromatin, which is a tightly packed form of chromatin 
and under gene silencing. 
  Among all of these modifications, methylation at H3K4, H3K9, H3K27, H3K36 and 
H3K79 and acetylation at H3K9/14 are of most importance. H3K9/14Ac usually results 
in a euchromatin state for active transcription of genes. However, different levels of 
methylation correspond to different chromatin states (29, 31, 32). For example, H3K4 
tri-methylation is associated with transcription activation and usually occurs near the 
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transcription start sites of actively transcribed genes (20, 31). 
 
 
 
 
Figure 4 Scheme of histone modification pathways 
 
 
 
  H3K9 tri-methylation and H3K27 tri-methylation are associated with transcription 
repression (31), but H3K9mono-methylation and H3K27mono-methylation are 
associated with transcription activation. H3K36 tri-methylation and H3K79 
di-methylation are associated with transcription elongation and occur within the body of 
transcriptionally active gene (20). In this work, we focus on H3K4 tri-methylation, 
H3K9 tri-methylation, H3K27 tri-methylation and H3K9/14 acetylation.  
  Originally used as a technique to detect DNA-protein interations, ChIP (chromatin 
immunoprecipitation) plays more and more important role in epigenetic study (34). The 
scheme of ChIP is shown in Figure 5. After fragmentation of DNA, specific antibodies 
are used to immunoprecipitate different proteins bound to DNA. Then 
DNA/protein/antibody complex is reversecross-linked, and the eluted DNA will be used 
for PCR, qPCR, direct sequencing, or microarray (35). 
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Figure 5 Scheme of Chromatin Immunoprecipitation (ChIP) 
 
 
 
  RNA profiling is a commonly used technique to obtain information about different 
genes’ expression levels. In our system, one-step qRT-PCR is used. Trizol extracted RNA 
is first reverse transcribed into cDNA by gene specific primers, then these primers are 
used to amplify cDNA exponentially to measure its level, which is indicative of original 
RNA level. Different RNA expression levels are usually caused by different states of 
cells, or more basically, different responses of cell to environment stimuli. 
  ELISA (enzyme-linked immunosorbent assay) is a widely used method to check the 
levels of target antigen in samples. Primary antibody binds to antigen first, and 
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enzyme-conjugated secondary antibody binds to primary antibody, which will cause the 
enzymatic color change of reactive substrate. Then through the extent of color change in 
the system, we can know the levels of target antigen in samples sensitively and easily. 
 1.3 A widely used matrix in tissue engineering--PEGDA 
  In this work, we will use PEG-based artificial matrices. PEG has many advantages for 
application in tissue engineering: 1. PEG is biocompatible, hydrophilic polymer, which 
can be used safely with cells and does not adsorb proteins (actually, it’s approved for in 
vivo use by FDA); 2. PEG has a well-established chemistry, which can form photo 
cross-linked network after acrylation; 3. matrices elasticity can be easily modulated 
through using of different molecular weight macromers (36). For these reasons, PEG is 
widely used in tissue engineering. Recently, the application of matrix metalloproteinase 
target peptide sequence (GPQGIWGQK) (12) imparts the ability of cell-based 
degradation to PEG matrices. Along with the pegylation of different growth factors to 
induce cell differentiation or tissue regeneration, a more advanced cell degradable, tissue 
regenerative matrix has been made to simulate in vivo extracellular environment more 
effectively (23). 
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2. EPIGENETIC STUDY OF MODEL SYSTEMS 
 2.1 Development of ChIP for 3D cell cultures 
 2.1.1 Summary 
  Before we investigate our model systems, we need to optimize experiment conditions 
to give reliable results. The most important step in ChIP is chromatin fragmentation. 
Over-fragmentation may diminish signal in the qPCR quantification, and 
under-fragmentation may cause increasing background signal and lower resolution. So 
our aim is to fragment chromatin to 150-450bp.In order to obtain the optimized 
chromatin fragments, namely, 150 to 450bp, we have tried 2 methods, sonication and 
enzymatic digestion. After that, we tested ChIP in 3D cell cultures. 
 2.1.2 Materials and methods 
  Fragmentation of chromatic DNA by sonication is done as following. Add 1% final 
concentration of formaldehyde (Sigma-Aldrich) to 2*10
6
 C3H/10T1/2 cells to cross-link 
proteins to DNA at room temperature (RT) for 10min with gentle shaking. Then add 
125mM final concentration of glycine (Fisher Scientific) to quench the formaldehyde 
with gentle shaking for 5min at RT. After that, rinse cells twice with 8ml ice-cold PBS 
(Sigma-Aldrich). Then scrape cells into 4ml PBS+PMSF (Sigma-Aldrich) (1mM final 
concentration), centrifuge at 1500rpm at 4
o
C for 5min. After that, resuspend cells in 
500ul ChIP buffer (Santa Cruz Biotechnology). Then cells are sonicated at different 
conditions to fragment chromatin. Fragmented chromatin is used in reverse cross-linking 
to analyze DNA fragmentation. 
  Enzymatic fragmentation of chromatic DNA is done as following. Add 1% final 
concentration of formaldehyde to 2*10
6
 C3H/10T1/2 cells to cross-link proteins to DNA 
at room temperature (RT) for 10min with gentle shaking. Then add 125mM final 
concentration of glycine to quench the formaldehyde with gentle shaking for 5min at RT. 
After that, rinse cells twice with 8ml ice-cold PBS. Then scrape cells into 4ml 
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PBS+PMSF (1mM final concentration), centrifuge at 1500rpm at 4
o
C for 5min. After 
that, resuspend cells in 500ul Buffer A+DTT+PIC+PMSF (Cell Signaling Technology) 
and incubate on ice for 10min with inverting tube every 3min. Then centrifuge at 
3000rpm for 5min at 4
o
C, resuspend pellet in 500ul Buffer B+DTT (Cell Signaling 
Technology). Repeat centrifugation, resuspend pellet in 50ul Buffer B+DTT. Add 1-5ul 
micrococcal nuclease (New England Biolabs) to digest chromatin at 37
o
C for 20min by 
inverting tube every 3min. Then stop digest by 100ul 0.5M EDTA (Cell Signaling 
Technology), centrifuge at 13000rpm for 1min at 4
o
C, resuspend pellet in 500ul ChIP 
buffer+PIC+PMSF (Cell Signaling Technology), incubate on ice for 10min. Then pellets 
are sonicated to break nuclear membrane. Centrifuge at 10000rpm for 10min at 4
o
C, 
supernatant is used in reverse cross-linking to analyze DNA fragmentation. 
  ChIP for C3H10T1/2 cells in PEGDA hydrogels is done as following. The same 
procedure is used to collect chromatin, except homogenizing hydrogels with microbeads 
to release cells, then using 0.12N NaOH to digest hydrogel particles for 24hrs after using 
glycine to quench formaldehyde. After that, 7.5ug specific antibodies (Santa Cruz 
Biotechnology) targeting different proteins are added to 100ul cross-linked 
chromatin+400ul ChIP buffer and incubated at 4
o
C overnight (o/n) with rotation. Then 
add 30ul protein G agarose beads (Cell Signaling Technology) and incubate at 4
o
C for 
2hrs with rotation. Then beads are washed sequentially with low salt wash buffer (Cell 
Signaling Technology) and high salt wash buffer (Cell Signaling Technology). After that, 
they are reversed cross-linked at 65
o
C for 2hrs to elute DNA. QIAquick PCR 
Purification Kits (Qiagen) are used to purify eluted DNA. 
  Real-time PCR is done as following. Real-time PCR are run in ABI7500 system 
(Applied Biosystems) with gene specific primers (SABiosciences), using ABI master 
mix (Applied Biosystems). 
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 2.1.3 Results 
  The effect of chromatin fragmentation by sonication is shown. Initially, we used 
sonication to fragment chromatin. Figure 6 shows the results of chromatin fragmentation 
under different sonication conditions. We tried different output powers and different 
number of cycles. Each cycle was composed of 10s sonication on ice and 10s pause on 
ice. We can see that although sonication time and intensity are increased, chromatin is 
still not fragmented very well. A large proportion of chromatin is still above 1kb, which 
means even the highest intensity and longest time are not enough for the fragmentation 
level we need.  
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Figure 6 Fragmented C3H/10T1/2 cells chromatin by sonication 
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  The effect of chromatin fragmentation by enzymatic digestion is shown. Due to the 
power limit of the sonicator, we can not use higher intensity. So we changed to 
enzymatic digestion. Micrococcal nuclease is able to induce double-strand breaks within 
nucleosome linker regions, but only single-strand nicks within the nucleosome itself. So 
it can be used to digest chromatin. Figure 7 shows the results of chromatin 
fragmentation using micrococcal nuclease. We can see that most chromatin is digested to 
the length of 1-3 nucleosomes. So we decided to use micrococcal nuclease to fragment 
chromatin in model systems. 
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Figure 7 Fragmented C3H/10T1/2 cells chromatin by enzymatic digestion 
 
 
 
  The result of ChIP for C3H10T1/2 cells in PEGDA hydrogels is shown. Next, we 
conducted ChIP in 3D cultures. C3H10T1/2 cells were encapsulated in 6k PEGDA 
hydrogel with 7.5*10
6
cells/ml PEG. After culturing in DMEM+10%d-FBS for 7days, 
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ChIP was performed with rat-anti-mouse SRF antibody. We found that after culturing in 
hydrogel for 7 days, about 1/240 of all SM-22a genes were bound by SRF, and about 1/4 
of all c-fos genes were bound by SRF (Figure 8).  
 
 
 
 
Figure 8 SRF enrichment of different genes in C3H10T1/2 cells encapsulated in PEGDA 
matrices 
 
 
 
 2.1.4 Discussion 
  From the above results, we can see that for our system, enzymatic digestion is better 
than sonication for chromatin fragmentation. This may be due to more control of 
enzymatic digestion. Moreover, for histone modification-based ChIP, we need to 
fragmentate chromatin to 150-450bp. But sonication is much weaker.  
  On the other hand, NaOH digestion followed by enzymatic digestion can be used to 
collect chromatin. We hypothesize that NaOH can digest hydrogel particles left after 
homogenization, which will help to release cells still trapped. The digestion time is very 
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important for over-digestion may cause the degradation of DNA.  
Moreover, SRF binding of SM-22a gene in C3H10T1/2 cells encapsulated in PEGDA 
hydrogels is important for their commitment into smooth muscle cells (SMC). 
  However, for ChIP in 3D cultures, a large number of punches (8) of hydrogels 
encapsulating cells are needed to collect enough chromatin, which is prohibitively high 
for sample demand compared to immunohistochemistry or RNA extraction (only need 2 
or 3 punches). Due to the limit of amount of samples, we decide to transit to 2D study, 
which is easier to get large amount of chromatin. 
 2.2 Growth factor stimulated systems 
 2.2.1 Summary 
  Growth factors are widely used to stimulate differentiation of mesenchymal stem cells. 
Through recognizing their corresponding receptors on the cell membrane, activating 
their specific signaling pathways, they are able to induce cell states changes. Here, we 
use TGF-b to stimulate C3H10T1/2 differentiation, and check modified histone binding 
to c-fos gene transcription start site, which is responsible for cell proliferation and to 
SM-22a gene transcription start site, which is a marker of differentiated smooth muscle 
cells (37). Next we use insulin to stimulate 3T3-L1 differentiation. 3T3-L1 cells have a 
very different differentiation potential compared to C3H10T1/2 cells. We will stimulate 
differentiation of 3T3-L1 cells (38), and compare cell states after stimulation to before 
stimulation from chromatin state and RNA expression level.  
 2.2.2 Materials and methods 
  C3H/10T1/2 differentiation is done as following. C3H/10T1/2 cells at passage 10 are 
stimulated with DMEM (Invitrogen) +10%d-FBS (Thermo Scientific) supplemented 
with 1ug/ml ascorbic acid (Sigma-Aldrich), 1 ng/ml TGF-b (Sigma-Aldrich). Media is 
changed every two days until day 7.  
  Other materials and methods are the same as in 2.1.2, except the antibodies used: 
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Histone H3 (tri methyl K4) antibody (Abcam), Histone H3 (tri methyl K27) antibody 
(Abcam). 
  3T3-L1 differentiation is done as following. 2 days post-confluence, 3T3-L1 cells are 
induced to differentiate with DMEM +10%FBS supplemented with 1μM dexamethasone 
(Sigma-Aldrich), 0.5mM isobutylmethylxanthine (Sigma-Aldrich) and 1μg/ml insulin 
(Sigma-Aldrich). After 2 days, the media is replaced with DMEM+10% FBS 
supplemented with 1μg/ml insulin. After 2 days, cells are fed every 48h with 
DMEM+10%FBS for 4 days. 
Other materials and methods are the same as in 2.1.2 and 2.3.2. 
 2.2.3 Results 
 2.2.3.1 TGFb treated C3H10T1/2 systems 
  Figure 9 shows relative enrichment of transcription start sites of c-fos, SM-22a and 
RPL30 genes in C3H10T1/2 cells after treated with TGF-b compared to enrichment in 
their original culture. We can see that H3K4me3 enrichment of SM-22a gene is 
statistically significantly greater than H3K27me3 enrichment of the same gene, which 
predicts that SM-22a gene is actively transcribed. On the other hand, H3K4me3 
enrichment of RPL30 gene is also greater than H3K27me3 enrichment of the same gene, 
which is a negative control. Even so, compared to times of which H3K4me3 enrichment 
of SM-22a is higher than H3K27me3 enrichment, we can still qualitatively find that 
SM-22a gene is actively transcribed. Due to the high standard deviation of H3K4me3 
enrichment of c-fos gene, we are not able to get any conclusion about this gene. 
 
20 
 
 
 
 
Figure 9 Relative histone enrichment of different genes in C3H10T1/2 cells 
 
 
 
 2.2.3.2 Insulin treated 3T3-L1 systems 
  Figure 10 shows relative enrichment of transcription start site of different genes in 
3T3-L1 cells after stimulation compared to enrichment in their original culture. We can 
see that H3K4me3 enrichment of transcription start site of Pparg is statistically elevated 
compared to H3K27me3 and H3K9me3 enrichment of the same gene, which predicts the 
increased expression level of Pparg RNA. The statistically different enrichment of 
IGX1A by differently modified histones, which is a negative control, indicates that there 
are different backgrounds in each immunoprecipitation. Again, this can only allow us to 
qualitatively predict that Pparg gene will have increased expression level. Increased 
expression level of Pparg RNA in Figure 11 supports the result. Moreover, the 
expression level of A-FABP RNA is also increased, which corresponds to the increased 
expression level of Pparg. 
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Figure 10 Relative histone enrichment of different genes in 3T3-L1 cells 
 
 
 
 
Figure 11 Relative RNA expression level of different genes in 3T3-L1 cells 
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 2.2.4 Discussion 
  From the results above, due to the differences in enrichment levels of negative 
controls (RPL30 and IGX1A) by different modified histones in each system and the high 
standard deviations in enrichment levels of some genes such as c-fos, we are not able to 
get any statistically significant conclusions. But qualitatively, we can see that TGF-b 
treated C3H/10T1/2 cells have more potential to become smooth muscle cells, and 
insulin treated 3T3-L1 cells have more potential to become adipocytes.  
  H3K4me3 enrichment of SM-22a gene promises elevated SM-22a RNA expression 
level, which in turn predicts increased SM-22a protein level. H3K4me3 enrichment of 
transcription start site of Pparg is increased, and Pparg and A-FABP RNA expression 
levels are also increased.   
  However, smooth muscle cells are only one lineage that C3H/10T1/2 cells can commit. 
It’s possible that they differentiate into other lineages. And this study is limited to 
C3H/10T1/2 mesenchymal stem cells only. Moreover, growth factors stimulation is not 
commonly used in tissue engineering to regenerate tissues, which is prohibitively 
expensive. On the other hand, SM-22a is only a smooth muscle cell marker regulated by 
transcription factor SRF. If we can detect differently modified histone binding to 
transcription factors specific in a cell lineage, we are able to predict cell states from a 
deeper level. 
  So we propose to study epigenetic changes of C3H/10T1/2 cells seeded on PEGDA 
matrices surface. PEG is a kind of widely used hydrogel, so this work will provide more 
meaningful perspective to apply epigenetic techniques in tissue engineering. Moreover, 
we will check more kinds of modified histone binding to transcription start sites of 
multiple transcription factors. This will provide a wider viewpoint of cell states. 
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 2.3 PEGDA matrix systems 
 2.3.1 Summary 
  Extracellular matrix (ECM) has very important effects on cell behaviors. In tissue 
engineering, it plays a even more important role for that it will determine viability of 
cells encapsulated in various scaffolds, responses of cells such as proliferation or 
differentiation (39). Actually, it is already verified that matrix with different modulus 
will cause human mesenchymal stem cells to commit into different lineages (10). For 
example, polyacrylamide matrix with small modulus will be neurogenic, while matrix 
with large modulus will be osteogenic. It is also verified that different moieties will 
cause human mesenchymal stem cells to commit into different lineages (21). For 
example, charged phosphate groups will be osteogenic, while hydrophobic t-butyl 
groups will be adipogenic. Based on these, we will study epigenetic changes in mouse 
mesenchymal stem cells seeded on PEG hydrogels. Mouse mesenchymal stem cells are 
similar to human mesenchymal stem cells, which are also pluripotent to differentiate 
various lineages and PEG hydrogels are similar to polyacrylamide, both of whose 
modulus can be adjusted by changing extent of cross-linking and macromers used. We 
will detect adipogenesis, chondrogenesis, and myogenesis of C3H/10T1/2 cells and 
NIH/3T3 cells using ChIP, then check the results from RNA and protein expression 
levels. 
 2.3.2 Materials and methods 
  Cell seeding and culturing is done as following. C3H10T1/2 cells at passage 15 and 
NIH/3T3 cells at passage 11are seeded at 10
4
cells/cm
2
. Before seeding, cells are treated 
with 8ug/ml mitomycin C (Sigma-Aldrich) for 4hrs to inhibit proliferation. After that, 
cells are trypsinized, collected and seeded on RGDS (American Peptide Company) 
tailored 20K 10% PEGDA (Sigma-Aldrich) hydrogel surfaces. Media is changed every 
two days until day 7. 
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  RNA extraction is done as following. Enough Trizol (Invitrogen) is used to 
homogenize cells for 5min at RT. After homogenization, add corresponding amount of 
chloroform (Sigma-Aldrich), shake rigorously and centrifuge at 10000rpm at 4
o
C for 
15min. After centrifugation, carefully transfer inorganic supernatant to a new tube, add 
equal volume of 70% ethanol (Sigma-Aldrich), mix thoroughly, then add solution to 
RNeasy columns (Qiagen) and centrifuge at 13000rpm for 30s. Repeat centrifugation 
until all the solution is added to the columns. Wash with Buffer RLP and RPE. Finally, 
elute RNA in 60ul nuclease-free water (Invitrogen). 
  Protein dialysis is done as following. Add corresponding amount of 100% ethanol 
(Sigma-Aldrich) to organic leftover after RNA extraction and centrifuge at 2000g at 4
o
C 
for 10min to get rid of rest DNA. Then put supernatant in 3500 MWCO (Thermo 
Scientific) dialysis membrane and dialyze against 0.1% SDS (Sigma-Aldrich) for 3 days 
or until the supernatant is colorless. After dialysis, centrifuge at 10000rpm at 4
o
C for 
10min, discard the supernatant and dissolve the pellet in 200ul cell lysis buffer (0.1% 
SDS, 0.5% Triton X-100 (Sigma-Aldrich) in PBS). 
  RT-PCR is done as following. Real-time RT-PCR are run in one step in ABI7500 
system with gene specific primers, using SuperScript III reverse transcriptase and 
Platinum
®
 Taq  DNA Polymerase mixture and 2X SYBR Green buffer (Invitrogen). 
  ELISA is done as following. Competitive blocking peptide (Santa Cruz Biotechnology) 
specific to target antigen (different cell lineage specific protein) is coated in a 
high-binding transparent plate o/n at 4
o
C. Next day, competitive ELISA is run. Briefly, 
samples are incubated with diluted 1
o
 antibody at RT for 1hr, and at the same time the 
plate is blocked with 3% BSA in PBST. After this, samples are added to the plate in 
duplicate and incubated at RT for 1hr. Then diluted 2
o
 antibody is added and incubated at 
RT for 45min. Finally, substrate ABTS (2, 2'-Azinobis 
[3-ethylbenzothiazoline-6-sulfonic acid]-diammonium salt) (Sigma) is added to the plate, 
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which will become a green product upon reaction with HRP, which is conjugated to 2
o
 
antibody. 
  Other materials and methods are the same as in 2.1.2. 
 2.3.3 Results 
  We compared the states of C3H10T1/2 cells and NIH/3T3 cells in their original 
culture, where they are supposed to proliferate, to the states when attached to PEG-based 
matrices surfaces, where they are supposed to differentiate into different cell lineages 
based on matrices elasticity. In each case, we collected chromatin, RNA and protein 
samples separately for different analysis. Here, RGDS is used as cell binding motif (40). 
 2.3.3.1 C3H/10T1/2 model system 
  Figure 12 shows relative enrichment of transcription start sites of different genes in 
C3H10T1/2 cells seeded on PEGDA surfaces compared to enrichment in their original 
culture. We can see that H3K4me3 enrichment of MyoD is greater than 1, which means 
MyoD gene is actively transcribed. However, H3K27me3 enrichment of MyoD is 
abnormally high. This may be due to the much higher background in H3K27me3 
immunoprecipitation, which is indicated by the higher H3K27me3 enrichment of 
negative control IGX1A than H3K4me3 enrichment. Figure 13 shows the relative 
expression level of corresponding genes, which is calculated as expression level after 
seeding on PEGDA surfaces relative to expression level in original culture. We can see 
that MyoD expression level is elevated, which agrees with that MyoD gene is actively 
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Figure 12 Relative histone enrichment of different genes in C3H10T1/2 cells 
 
 
 
 
Figure 13 Relative RNA expression level of different genes in C3H10T1/2 cells 
 
 
 
transcribed. Moreover, from the gene expression level of cell lineage specific markers, 
which is controlled by its own transcription factor (Sox9, Pparg and MyoD are 
transcription factors for Coll2A, A-FABP and SM-22a, respectively), we found that the 
increased expression level of SM-22a is consistent with the increased expression level of 
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MyoD (Figure 14). ELISA result of different protein levels is somehow different from 
previous ChIP and gene expression profiling results (Figure 15). This may be caused by 
the unequal correlation between RNA expression level and protein expression level. And 
due to the high standard deviations in the assay, we can not get any statistical 
conclusions. 
 
 
 
 
Figure 14 Relative RNA expression level of cell markers in C3H10T1/2 cells 
 
 
 
 
Figure 15 Relative protein expression levels in C3H10T1/2 cells 
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 2.3.3.2 NIH/3T3 model system 
  Similarly, Figure 16 shows relative enrichment of transcription start sites of different 
genes in NIH/3T3 cells seeded on PEGDA surfaces compared to enrichment in their 
original culture. We can see that H3K4me3 enrichment of MyoD is greater than 1, which 
means MyoD gene is actively transcribed. Here, we also found that H3K27me3 
enrichment of MyoD is abnormally high. This may also be resulted from the high 
background in H3K27me3 immunoprecipitations. Figure 17 shows the relative 
expression level of corresponding genes, which is calculated as expression level after 
seeding on PEGDA surfaces compared to expression level in original culture. We can see 
that MyoD expression level is statistically elevated, which agrees with that MyoD gene 
is actively transcribed from chromatin state. Due to the high standard deviation in the  
 
 
 
 
Figure 16 Relative histone enrichment of different genes in NIH/3T3 cells 
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Figure 17 Relative RNA expression level of different genes in NIH/3T3 cells 
 
 
 
 
Figure 18 Relative RNA expression level of cell markers in NIH/3T3 cells 
 
 
expression level of cell lineage specific markers, we can not get any statistical 
conclusions about their expression. But we can still see that SM-22a expression level is 
qualitatively increased (Figure 18). ELISA result is somehow different from previous 
results (Figure 19). This may be caused by 2 reasons: 1. the high standard deviations in 
the assay make it impossible to get any statistical conclusions; 2. the correlation between 
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RNA expression level and protein expression level is unequal.  
 
 
 
 
Figure 19 Relative protein expression level in NIH/3T3 cells 
 
 
 
 2.3.4 Discussion 
  Analysis of results above revealed that epigenetic states are changed after cells 
attached to matrices surfaces. As a result of the high standard deviations in the assay and 
the high background in H3K27me3 immunoprecipitations, we are not able to get any 
statistically significant conclusions.  
But we can still see qualitatively that H3K4me3 enrichment of MyoD is greater than 1 
in both C3H10T1/2 cells and NIH/3T3 cells, which predicts higher expression levels of 
myogenic markers. qRT-PCR using corresponding gene specific primers gives a similar 
profile predicted from epigenetic states: MyoD expression level is elevated, and SM-22a 
expression level is also increased, which is controlled by MyoD.  
  However, C3H10T1/2 cells have higher potential to be myogenic, which are 
determined by their origin. So this is a drawback of the study. Moreover, we can see 
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increased histone enrichment of other genes and increased RNA expression level of 
other genes. These non-specific increases may be caused by the detection limit of the 
methods. To get reliable results, at least 4*10
6
cells are needed to perform 1 IP 
(immunoprecipitation). Due to the limit to get enough samples, we could not have so 
many cells for IP, which may cause the results to be a little aberrant. The non-specific 
increases may also be resulted from the less important role of matrix elasticity in stem 
cell differentiation. The modulus of PEGDA hydrogels used in the study is in the range 
for adipogenesis and osteogenesis, which may not be so specific for myogenesis. So 
other cell lineage specific genes could also have elevated expression levels. 
  Anyhow, from the results above, we can still see that ChIP-based epigenetic method is 
promising in detecting stem cell states. 
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3. CONCLUSIONS AND FUTURE DIRECTIONS 
 3.1 Conclusions 
  Our data provides some preliminary perspectives on how ChIP-based epigenetic 
techniques can be used in tissue engineering to analyze stem cell states. After we set up 
the experiment system and optimized conditions, we run experiments in several model 
systems.  
  Due to the high standard deviations and the large differences in the enrichment level 
of negative controls in different immunoprecipitaions caused by the high background in 
them, it is very difficult to get statistically significant conclusions. However, we can still 
get some qualitative conclusions about trends of different model cells. 
  For PEGDA matrix systems, the compression moduli of the matrix are around 40kPa, 
which is similar to the moduli of muscle tissues (10). Both C3H/10T1/2 and NIH/3T3 
cells seeded on the matrices showed higher tendancy to differentiate into muscle tissues, 
as is identified by higher H3K4me3 enrichment at the transcription start site of MyoD 
gene from chromatin state, and higher MyoD and SM-22a expression levels from RNA 
state. This is consistent with the prediction of cell states based on the matrices elasticity. 
Moreover, more transcription start sites of MyoD are bound by H3K4me3 determines 
the higher expression levels of MyoD and SM-22a RNA. This is consistent with the 
central dogma in molecular biology.    
  Furthermore, 3T3-L1 cells are pre-adipocytes, and upon induction, they will 
differentiate into mature adipocytes. The higher H3K4me3 enrichment of transcription 
start site of Pparg and the higher Pparg and A-FABP RNA expression levels after 
differentiation identify that differentiation is not fake. Although we did not check the 
protein expression levels of Pparg and A-FABP, we detected the morphological change 
and oil droplets accumulation during differentiation (data not shown). 
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  In summary, ChIP-based epigenetic techniques are promising methods to check stem 
cell states. They can provide information of future cell lineages from a more 
fundamental level than flow cytometric profiling. If combined together with gene 
expression profiling or protein exression assay, more complete information can be 
obtained, which will help people to understand mesenchymal stem cell states and their 
differentiation process more clearly, more deeply and more fundamentally. This will be 
very beneficent for using mesenchymal stem cells in tissue engineering. 
 3.2 Future directions 
  In the work above, we have shown that ChIP-based epigenetic techniques can be used 
to detect stem cell states for tissue engineering applications with differently modified 
histone enrichment at transcription start sites of different genes. Moreover, RNA 
profiling and protein expression level test can be used to support the conclusion obtained 
from epigenetic study. 
  We propose to build on these results in two distinct goals. First, we propose to study 
the effects of matrices with varying moduli on stem cell differentiation. Second, we will 
further study epigenetic changes in 3D cell cultures, which are more similar to cells in 
vivo.  
 3.2.1 Effects of matrices elasticity on stem cell differentiation 
  We can hypothesize matrices with different elasticity lead to different fates of stem 
cells. 
  In our preliminary experiments, PEGDA matrices whose moduli are in the range of 
muscle tissues direct stem cells to muscle-like cells. Actually, the effects of matrix 
elasticity on stem cell differentiation have been studied a lot (10). So we propose to 
investigate differently modified histone enrichment at transcription start sites of different 
genes specific for different cell lineages derived from the same progenitor cells. 
  We will use different molecular weight PEGDA to create matrices with different 
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moduli. Using the same procedure, we will check the epigenetic changes of stem cells 
seeded on matrices surfaces after culturing for 7 days compared to their states in original 
culture. On the other hand, Trizol-based RNA extraction will be done, which will be 
used in qRT-PCR to identify corresponding gene expression level. If necessary, ELISA 
will also be run to identify from protein expression level. We will focus on 
chondrogenesis specific genes, Sox9 and Col2A, adipogenesis specific genes, Pparg and 
A-FABP, myogenesis specific genes, MyoD and SM-22a and osteogenesis specific genes, 
Runx2 and Osteocalcin.  
  Based on our preliminary results, we can predict that H3K4me3 enrichment of 
transcription start site of specific gene corresponds to the cell lineage dictated by the 
elasticity of matrices on which stem cells are seeded. Moreover, corresponding gene 
expression level will also be elevated. We can also use ChIP-on-chip technique to 
analyze genome wide histone binding, which can give us a more complete view of the 
cell states. 
 3.2.2 Epigenetic changes in 3D cell cultures 
  We can hypothesize 3D cell cultures are more effective in stem cell differentiation and 
more similar to cells in vivo. 
  3D cell cultures are becoming more and more important for they mimic cells in vivo 
(surrounded by their natural extracellular matrix), while 2D cell cultures have large 
differences with cells in vivo. Moreover, a lot of studies have been done in 3D cell 
cultures (41). So we propose to investigate epigenetic changes in 3D cell cultures.  
  We will encapsulate stem cells in PEGDA matrices. After culturing for 7 days, we will 
use microbeads to homogenize these matrices. After homogenization, cells will be 
released from hydrogels and then we can collect chromatin, RNA and protein samples. 
Then the same procedure will be done with these samples to check cell states from 
different levels. Then the states after encapsulating in matrices are compared with the 
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states in original culture to get a conclusion about differentiation. 
  We can predict that cells will differentiate, but we need to check very carefully which 
lineage they are directed to. We can use cell specific induction media to control their 
fates more specifically.  
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